| 22/06 | KRYSTAL BIOTECH : Submits Biologics License Application to U.S. FDA Seeking Approval of B-.. |  |
| 22/06 | KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form .. | |
| 22/06 | Krystal Biotech Files Biologics License Application With FDA for Skin Disease Drug Cand.. | |
| 22/06 | Krystal Biotech Submits Biologics License Application to U.S. FDA Seeking Approval of B.. | |
| 22/06 | Krystal Biotech Submits Biologics License Application to U.S. FDA Seeking Approval of B.. | |
| 15/06 | TRANSCRIPT : Krystal Biotech, Inc. Presents at Goldman Sachs 43rd Annual Global Healthcare.. | |
| 07/06 | Krystal Biotech to Present at Goldman Sachs 43rd Annual Global Healthcare Conference | |
| 26/05 | KRYSTAL BIOTECH, INC. : Changes in Registrant's Certifying Accountant, Financial Statement.. | |
| 23/05 | KRYSTAL BIOTECH, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) | |
| 20/05 | KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form .. | |
| 20/05 | Krystal Biotech to Present Additional Data on B-VEC from the GEM-3 Phase 3 Study at the.. | |
| 10/05 | TRANSCRIPT : Krystal Biotech, Inc. Presents at Bank of America 2022 Healthcare Conference,.. | |
| 09/05 | Earnings Flash (KRYS) KRYSTAL BIOTECH Reports Q1 Loss $-1.99 | |
| 09/05 | Krystal Biotech Announces First Quarter 2022 Financial Results and Reports Updates on O.. | |
| 09/05 | KRYSTAL BIOTECH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND .. | |
| 09/05 | Krystal Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 20.. | |
| 03/05 | Krystal Biotech to Participate in Bank of America Merrill Lynch Global Healthcare Confe.. | |
| 11/04 | Krystal Biotech Plans Home-Dosing Option in Study of Investigational Skin Disorder Ther.. | |
| 11/04 | Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study | |
| 11/04 | Krystal Biotech Announces Home Dosing in B-Vec Open Label Extension Study | |
| 28/03 | KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form .. | |
| 28/03 | Krystal Biotech Says Trial of Skin Disease Treatment Met Primary and Secondary Endpoint.. | |
| 28/03 | Krystal Biotech Announces Publication of Phase 1 and 2 Clinical Trial (GEM 1/2 Study) o.. | |
| 28/03 | Krystal Biotech Announces Publication of Phase 1 and 2 Clinical Trial (GEM 1/2 Study) o.. | |
| 28/03 | TRANSCRIPT : Krystal Biotech, Inc. - Special Call | |
| 28/03 | Krystal Biotech, Inc. - New GEM-3 Phase 3 Results for B-VEC Presented at 2022 American .. | |
| 26/03 | New GEM-3 Phase 3 Results for B-VEC Presented at 2022 American Academy of Dermatology A.. | |
| 26/03 | Krystal Biotech, Inc., Announces New GEM-3 Phase 3 Results for B-VEC Presented at 2022 .. | |
| 24/03 | Krystal Biotech to Participate in H.C. Wainwright and Guggenheim Investor Conferences | |
| 23/03 | Jeune Aesthetics Announces Positive Clinical Phase 1 (PEARL-1 Study) Efficacy Results f.. | |
| 22/03 | KRYSTAL BIOTECH : Jeune Aesthetics Announces Positive Clinical Phase 1 (PEARL-1 Study) Eff.. | |
| 22/03 | KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form .. | |
| 22/03 | TRANSCRIPT : Jeune Aesthetics, Inc, Krystal Biotech, Inc. - Special Call | |
| 21/03 | Krystal Biotech to Present at 2022 American Academy of Dermatology Annual Meeting | |
| 18/03 | Krystal Biotech to Present at 2022 American Academy of Dermatology Annual Meeting | |
| 15/03 | KRYSTAL BIOTECH : Announces Settlement with PeriphaGen, Inc - Form 8-K | |
| 15/03 | KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form .. | |
| 15/03 | Krystal Biotech Settles Litigation With PeriphaGen | |
| 15/03 | Krystal Biotech Announces Settlement with PeriphaGen, Inc. | |
| 01/03 | KRYSTAL BIOTECH : Reports Fourth Quarter and Full Year 2021 Financial Results and Provides.. | |
| 28/02 | KRYSTAL BIOTECH, INC. : Results of Operations and Financial Condition, Change in Directors.. | |
| 28/02 | Krystal Biotech, Inc. Announces Board Changes | |
| 28/02 | Krystal Biotech's Q4 Loss Widens | |
| 28/02 | KRYSTAL BIOTECH, INC. Management's Discussion and Analysis of Financial Condition and .. | |
| 28/02 | Krystal Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 202.. | |
| 28/02 | Krystal Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Provide.. | |
| 28/02 | NORTH AMERICAN MORNING BRIEFING : Stock Futures -3- | |
| 28/02 | Certain Commom Stock of Krystal Biotech, Inc. are subject to a Lock-Up Agreement Ending.. | |
| 28/02 | Certain Restricted Stock Units of Krystal Biotech, Inc. are subject to a Lock-Up Agreem.. | |
| 28/02 | Certain Stock Options of Krystal Biotech, Inc. are subject to a Lock-Up Agreement Endin.. | |
| 24/02 | Krystal Biotech to Participate in Cowen's 42nd Annual Health Care Conference | |
| 18/01 | KRYSTAL BIOTECH : Appoints Jing Marantz, MD, PhD, MBA as Chief Business Officer and Rand S.. | |
| 18/01 | KRYSTAL BIOTECH, INC. : Change in Directors or Principal Officers, Regulation FD Disclosur.. | |
| 18/01 | Krystal Biotech Appoints Jing Marantz, MD, PhD, MBA as Chief Business Officer and Rand .. | |
| 18/01 | Krystal Biotech, Inc. Announces Management Changes | |
| 2021 | INSIDER SELL : Krystal Biotech | |
| 2021 | INSIDER SELL : Krystal Biotech | |
| 2021 | KRYSTAL BIOTECH, INC. : Entry into a Material Definitive Agreement, Financial Statements a.. | |
| 2021 | Krystal Biotech Prices $200 Million Offering at $75/Share | |
| 2021 | Krystal Biotech Announces Pricing of $200 Million Public Offering of Common Stock | |
| 2021 | Krystal Biotech Starts $200 Million Share Sale | |
| 2021 | Krystal Biotech Announces Proposed $200 Million Public Offering of Common Stock | |
| 2021 | KRYSTAL BIOTECH : Announces Positive Topline Results from GEM-3 Pivotal Trial of VYJUVEK&#.. | |
| 2021 | KRYSTAL BIOTECH, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form .. | |
| 2021 | Health Care Stocks Hanging On For Narrow Gains Near Monday Close | |
| 2021 | Krystal Biotech Genetic Skin Disorder Drug Trial Meets Primary Endpoint; Shares Rally | |
| 2021 | Health Care Stocks Rising Monday Afternoon | |
| 2021 | Top Midday Gainers | |
| 2021 | Wall Street Set for Rebound After Omicron-Induced Slump | |
| 2021 | Health Care Stocks Rally Premarket Monday | |
| 2021 | Health Care | |
| 2021 | Top Premarket Gainers | |
| 2021 | Krystal Biotech Soars Premarket as Genetic Skin Disorder Drug Trial Meets Primary Endpo.. | |
| 2021 | TRANSCRIPT : Krystal Biotech, Inc. - Special Call | |
| 2021 | Krystal Biotech Shares More Than Double After Dystrophic EB Trial Meets Objectives | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
